Selected research
Industry Research
Azithromycin Drug Industry Research Report 2026
Market perspective
The global Azithromycin Drug market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Azithromycin Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Azithromycin Drug is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Azithromycin Drug is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Azithromycin Drug include Teva, Sandoz, Mylan, Pfizer, Hainan Poly Pharm, Hainan Hailing Chemipharma Corporation, Zydus Pharmaceuticals, Wockhardt and PLIVA, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Azithromycin Drug market in terms of revenue (US$ million) and, where applicable, sales volume (W Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/W Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Azithromycin Drug Market by Company
Teva
Sandoz
Mylan
Pfizer
Hainan Poly Pharm
Hainan Hailing Chemipharma Corporation
Zydus Pharmaceuticals
Wockhardt
PLIVA
Lupin
Gland Pharma Limited
CSPC Ouyi Pharmaceutical
CSPC
Aurobindo Pharma
Akorn
Azithromycin Drug Segment by Type
Oral
Injection
Azithromycin Drug Segment by Application
Hospital
Drug Store
Azithromycin Drug Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Azithromycin Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Azithromycin Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Azithromycin Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Azithromycin Drug manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Azithromycin Drug by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Azithromycin Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Oral
- Injection
Applications
- Hospital
- Drug Store
Companies covered
- Teva
- Sandoz
- Mylan
- Pfizer
- Hainan Poly Pharm
- Hainan Hailing Chemipharma Corporation
- Zydus Pharmaceuticals
- Wockhardt
- PLIVA
- Lupin
- Gland Pharma Limited
- CSPC Ouyi Pharmaceutical
- CSPC
- Aurobindo Pharma
- Akorn
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Azithromycin Drug Market Size (2021-2032)
- 2.2.2 Global Azithromycin Drug Sales (2021-2032)
- 2.2.3 Global Azithromycin Drug Market Average Price (2021-2032)
- 2.3 Azithromycin Drug by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Oral
- 2.3.3 Injection
- 2.4 Azithromycin Drug by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Drug Store
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Azithromycin Drug Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Azithromycin Drug Sales (W Units) of Manufacturers (2021-2026)
- 3.3 Global Azithromycin Drug Revenue of Manufacturers (2021-2026)
- 3.4 Global Azithromycin Drug Average Price by Manufacturers (2021-2026)
- 3.5 Global Azithromycin Drug Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Azithromycin Drug, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Azithromycin Drug, Product Type & Application
- 3.8 Global Manufacturers of Azithromycin Drug, Established Date
- 3.9 Global Azithromycin Drug Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Teva
- 4.1.1 Teva Company Information
- 4.1.2 Teva Business Overview
- 4.1.3 Teva Azithromycin Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Teva Azithromycin Drug Product Portfolio
- 4.1.5 Teva Recent Developments
- 4.2 Sandoz
- 4.2.1 Sandoz Company Information
- 4.2.2 Sandoz Business Overview
- 4.2.3 Sandoz Azithromycin Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Sandoz Azithromycin Drug Product Portfolio
- 4.2.5 Sandoz Recent Developments
- 4.3 Mylan
- 4.3.1 Mylan Company Information
- 4.3.2 Mylan Business Overview
- 4.3.3 Mylan Azithromycin Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Mylan Azithromycin Drug Product Portfolio
- 4.3.5 Mylan Recent Developments
- 4.4 Pfizer
- 4.4.1 Pfizer Company Information
- 4.4.2 Pfizer Business Overview
- 4.4.3 Pfizer Azithromycin Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Pfizer Azithromycin Drug Product Portfolio
- 4.4.5 Pfizer Recent Developments
- 4.5 Hainan Poly Pharm
- 4.5.1 Hainan Poly Pharm Company Information
- 4.5.2 Hainan Poly Pharm Business Overview
- 4.5.3 Hainan Poly Pharm Azithromycin Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Hainan Poly Pharm Azithromycin Drug Product Portfolio
- 4.5.5 Hainan Poly Pharm Recent Developments
- 4.6 Hainan Hailing Chemipharma Corporation
- 4.6.1 Hainan Hailing Chemipharma Corporation Company Information
- 4.6.2 Hainan Hailing Chemipharma Corporation Business Overview
- 4.6.3 Hainan Hailing Chemipharma Corporation Azithromycin Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Hainan Hailing Chemipharma Corporation Azithromycin Drug Product Portfolio
- 4.6.5 Hainan Hailing Chemipharma Corporation Recent Developments
- 4.7 Zydus Pharmaceuticals
- 4.7.1 Zydus Pharmaceuticals Company Information
- 4.7.2 Zydus Pharmaceuticals Business Overview
- 4.7.3 Zydus Pharmaceuticals Azithromycin Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Zydus Pharmaceuticals Azithromycin Drug Product Portfolio
- 4.7.5 Zydus Pharmaceuticals Recent Developments
- 4.8 Wockhardt
- 4.8.1 Wockhardt Company Information
- 4.8.2 Wockhardt Business Overview
- 4.8.3 Wockhardt Azithromycin Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Wockhardt Azithromycin Drug Product Portfolio
- 4.8.5 Wockhardt Recent Developments
- 4.9 PLIVA
- 4.9.1 PLIVA Company Information
- 4.9.2 PLIVA Business Overview
- 4.9.3 PLIVA Azithromycin Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 PLIVA Azithromycin Drug Product Portfolio
- 4.9.5 PLIVA Recent Developments
- 4.10 Lupin
- 4.10.1 Lupin Company Information
- 4.10.2 Lupin Business Overview
- 4.10.3 Lupin Azithromycin Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Lupin Azithromycin Drug Product Portfolio
- 4.10.5 Lupin Recent Developments
- 4.11 Gland Pharma Limited
- 4.11.1 Gland Pharma Limited Company Information
- 4.11.2 Gland Pharma Limited Business Overview
- 4.11.3 Gland Pharma Limited Azithromycin Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Gland Pharma Limited Azithromycin Drug Product Portfolio
- 4.11.5 Gland Pharma Limited Recent Developments
- 4.12 CSPC Ouyi Pharmaceutical
- 4.12.1 CSPC Ouyi Pharmaceutical Company Information
- 4.12.2 CSPC Ouyi Pharmaceutical Business Overview
- 4.12.3 CSPC Ouyi Pharmaceutical Azithromycin Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 CSPC Ouyi Pharmaceutical Azithromycin Drug Product Portfolio
- 4.12.5 CSPC Ouyi Pharmaceutical Recent Developments
- 4.13 CSPC
- 4.13.1 CSPC Company Information
- 4.13.2 CSPC Business Overview
- 4.13.3 CSPC Azithromycin Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 CSPC Azithromycin Drug Product Portfolio
- 4.13.5 CSPC Recent Developments
- 4.14 Aurobindo Pharma
- 4.14.1 Aurobindo Pharma Company Information
- 4.14.2 Aurobindo Pharma Business Overview
- 4.14.3 Aurobindo Pharma Azithromycin Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Aurobindo Pharma Azithromycin Drug Product Portfolio
- 4.14.5 Aurobindo Pharma Recent Developments
- 4.15 Akorn
- 4.15.1 Akorn Company Information
- 4.15.2 Akorn Business Overview
- 4.15.3 Akorn Azithromycin Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Akorn Azithromycin Drug Product Portfolio
- 4.15.5 Akorn Recent Developments
5 Global Azithromycin Drug Market Scenario by Region
- 5.1 Global Azithromycin Drug Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Azithromycin Drug Sales by Region: 2021-2032
- 5.2.1 Global Azithromycin Drug Sales by Region: 2021-2026
- 5.2.2 Global Azithromycin Drug Sales by Region: 2027-2032
- 5.3 Global Azithromycin Drug Revenue by Region: 2021-2032
- 5.3.1 Global Azithromycin Drug Revenue by Region: 2021-2026
- 5.3.2 Global Azithromycin Drug Revenue by Region: 2027-2032
- 5.4 North America Azithromycin Drug Market Facts & Figures by Country
- 5.4.1 North America Azithromycin Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Azithromycin Drug Sales by Country (2021-2032)
- 5.4.3 North America Azithromycin Drug Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Azithromycin Drug Market Facts & Figures by Country
- 5.5.1 Europe Azithromycin Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Azithromycin Drug Sales by Country (2021-2032)
- 5.5.3 Europe Azithromycin Drug Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Azithromycin Drug Market Facts & Figures by Country
- 5.6.1 Asia Pacific Azithromycin Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Azithromycin Drug Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Azithromycin Drug Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Azithromycin Drug Market Facts & Figures by Country
- 5.7.1 South America Azithromycin Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Azithromycin Drug Sales by Country (2021-2032)
- 5.7.3 South America Azithromycin Drug Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Azithromycin Drug Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Azithromycin Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Azithromycin Drug Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Azithromycin Drug Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Azithromycin Drug Sales by Type (2021-2032)
- 6.1.1 Global Azithromycin Drug Sales by Type (2021-2032) & (W Units)
- 6.1.2 Global Azithromycin Drug Sales Market Share by Type (2021-2032)
- 6.2 Global Azithromycin Drug Revenue by Type (2021-2032)
- 6.2.1 Global Azithromycin Drug Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Azithromycin Drug Revenue Market Share by Type (2021-2032)
- 6.3 Global Azithromycin Drug Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Azithromycin Drug Sales by Application (2021-2032)
- 7.1.1 Global Azithromycin Drug Sales by Application (2021-2032) & (W Units)
- 7.1.2 Global Azithromycin Drug Sales Market Share by Application (2021-2032)
- 7.2 Global Azithromycin Drug Revenue by Application (2021-2032)
- 7.2.1 Global Azithromycin Drug Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Azithromycin Drug Revenue Market Share by Application (2021-2032)
- 7.3 Global Azithromycin Drug Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Azithromycin Drug Value Chain Analysis
- 8.1.1 Azithromycin Drug Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Azithromycin Drug Production Mode & Process
- 8.2 Azithromycin Drug Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Azithromycin Drug Distributors
- 8.2.3 Azithromycin Drug Customers
9 Global Azithromycin Drug Analyzing Market Dynamics
- 9.1 Azithromycin Drug Industry Trends
- 9.2 Azithromycin Drug Industry Drivers
- 9.3 Azithromycin Drug Industry Opportunities and Challenges
- 9.4 Azithromycin Drug Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst